Nurse Practitioner, Adult Health · Flushing, NY
NPI
1427301902
Since 2012
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3502 150th Pl
Flushing, NY, 11354
Phone (347) 368-6691
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
1,140 services
Medicare patients, 2024
67
Average age 76
Drug cost, 2024
$5.5M
27,111 prescriptions
Company payments, 2025
$1,862
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yunkyoung Jeong was code 99214 (office e&m - established), 115 times for 34 patients. In total Yunkyoung Jeong billed 1,140 services in 27 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 115 | 34 | $94.06 | $11K |
| 99215 Office E&M - Established | Office | 100 | 36 | $128.84 | $13K |
| 36415 Venipuncture Blood Collection | Office | 46 | 32 | $8.65 | $398 |
| 99213 Office E&M - Established | Office | 43 | 21 | $67.60 | $2,907 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 19 | 19 | $123.07 | $2,338 |
| 99204 Office E&M - New | Office | 15 | 15 | $101.32 | $1,520 |
| G0008 Administration of influenza virus vaccine | Office | 15 | 15 | $36.42 | $546 |
| 90656 Vaccine Product | Office | 12 | 12 | $21.90 | $263 |
By year: 2022 $70K for 1,145 services; 2023 $55K for 1,679 services; 2024 $43K for 1,140 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 46 | 32 | $8.65 | $398 |
Medicare prescription drug claims, 2024
In 2024, the drug Yunkyoung Jeong prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 1,761 prescriptions and refills. In total Yunkyoung Jeong wrote 27,111 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 1,761 | 2,089 | 256 | $706K |
| Atorvastatin Calcium Generic | 1,565 | 2,385 | 287 | $6,550 |
| Diclofenac Epolamine Generic | 1,251 | 1,436 | 202 | $916K |
| Amlodipine Besylate Generic | 1,082 | 1,542 | 190 | $3,545 |
| Metformin Hcl Generic | 806 | 1,129 | 142 | $2,678 |
| Losartan Potassium Generic | 803 | 1,196 | 132 | $3,106 |
| Tamsulosin Hcl Generic | 772 | 1,049 | 130 | $3,091 |
| Mirtazapine Generic | 711 | 961 | 135 | $10K |
| Omeprazole Generic | 661 | 914 | 177 | $5,600 |
| Creon Lipase/Protease/Amylase | 617 | 687 | 118 | $599K |
| Simvastatin Generic | 615 | 896 | 101 | $2,196 |
| Meclizine Hcl Generic | 557 | 611 | 171 | $5,462 |
| Restasis Cyclosporine | 497 | 582 | 85 | $370K |
| Donepezil Hcl Generic | 476 | 603 | 74 | $2,075 |
| Alendronate Sodium Generic | 449 | 670 | 92 | $2,031 |
Brand drugs: 7,784 claims; generic drugs: 19,015 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yunkyoung Jeong $1,862 ($1,862 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $326.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $326 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 21 | $295 |
| Novo Nordisk Inc NVO | 10 | $230 |
| Amgen Inc. AMGN | 5 | $209 |
| Axsome Therapeutics, Inc. AXSM | 8 | $206 |
| Almatica Pharma LLC | 7 | $170 |
| Lundbeck LLC | 5 | $100 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $98.36 |
| Aimmune Therapeutics, Inc. | 5 | $97.82 |
| Exact Sciences Corporation EXAS | 4 | $80.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.